Chopra Pooja, Talwar Vandana
Department of Anesthesia and Intensive Care, Vardhman Mahavir Medical College and Safdarjang Hospital, New Delhi, India.
J Anaesthesiol Clin Pharmacol. 2014 Apr;30(2):233-7. doi: 10.4103/0970-9185.130029.
We undertook this study to ascertain if a small dose of clonidine (30 μg) when added to a bupivacaine-fentanyl mixture improves spinal analgesia, without producing side effects, as compared to a bupivacaine-fentanyl or a bupivacaine-clonidine mixture.
In this prospective, randomized, double-blind study, 75 (American Society of Anesthesiologists) ASA grade I-II patients, aged between 45 and 65 years, who were scheduled for vaginal hysterectomy with pelvic floor repair or non-descent vaginal hysterectomy under spinal anesthesia were recruited. The patients received hyperbaric bupivacaine (2.3 ml) with fentanyl 15 μg (Group BF) or clonidine 30 μg (Group BC) or both fentanyl (15 μg) and clonidine (30 μg) (Group BCF). The total amount of intrathecal mixture was constant (2.8 ml) in all the groups. Duration of sensory, motor block and effective analgesia, hemodynamic profile, postoperative pain score and analgesic requirements were recorded.
The duration of effective analgesia, mean time till two-segment regression, and duration of sensory and motor block were significantly longer in group BCF as compared to group BC (P ~ 0.002), and in group BC as compared to group BF (P ~ 0.01). The incidence of intraoperative pain and requirement of postoperative analgesics in the first 24 hours was significantly more in group BF as compared to the other groups (P ~ 0.01). There was no difference in the hemodynamic profile between the groups.
Low-dose clonidine (30 μg) when added to a bupivacaine-fentanyl mixture increased the duration of effective analgesia and the duration of sensory and motor block in gynecological surgery. The incidence of intraoperative pain and requirement of postoperative analgesics was significantly less when clonidine was added to intrathecal bupivacaine with or without fentanyl.
我们开展这项研究以确定,与布比卡因 - 芬太尼混合物或布比卡因 - 可乐定混合物相比,在布比卡因 - 芬太尼混合物中添加小剂量可乐定(30μg)是否能改善脊髓镇痛效果且不产生副作用。
在这项前瞻性、随机、双盲研究中,招募了75例年龄在45至65岁之间、美国麻醉医师协会(ASA)分级为I - II级、计划在脊髓麻醉下进行阴道子宫切除术加盆底修复或非脱垂性阴道子宫切除术的患者。患者接受含15μg芬太尼的重比重布比卡因(2.3ml)(BF组)或含30μg可乐定的重比重布比卡因(BC组)或同时含15μg芬太尼和30μg可乐定的重比重布比卡因(BCF组)。所有组鞘内混合物总量恒定(2.8ml)。记录感觉、运动阻滞及有效镇痛持续时间、血流动力学情况、术后疼痛评分及镇痛需求。
与BC组相比,BCF组有效镇痛持续时间、至两级消退的平均时间以及感觉和运动阻滞持续时间显著更长(P约为0.002);与BF组相比,BC组上述指标显著更长(P约为0.01)。与其他组相比,BF组术中疼痛发生率及术后24小时内镇痛药物需求显著更高(P约为0.01)。各组间血流动力学情况无差异。
在布比卡因 - 芬太尼混合物中添加低剂量可乐定(30μg)可延长妇科手术中有效镇痛持续时间以及感觉和运动阻滞持续时间。在鞘内布比卡因中添加可乐定(无论是否含芬太尼)时,术中疼痛发生率及术后镇痛药物需求显著更低。